Orion Biotechnology Canada Announces Partnership with Nanjing University

OTTAWA, March 28, 2018 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a developer of novel medical treatments for chronic illness and life-threatening diseases, today announced a strategic partnership with the Center for Public Health Research (CPHR) and the State Key Laboratory of Analytical Chemistry (SKLAC) of Nanjing University. The partnership will focus on supporting the … Read moreOrion Biotechnology Canada Announces Partnership with Nanjing University

Orion Biotechnology Canada Announces Appointment of Mark Groper as President & CEO

OTTAWA, Ontario (PRWEB)March 26, 2018 Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that Mark Groper has joined as the company’s new President, CEO and a member of the board of directors. Rudolf Bom, who served as the company’s founder and CEO since 2011, will assume the position of Chairman of … Read moreOrion Biotechnology Canada Announces Appointment of Mark Groper as President & CEO

Orion Biotechnology Canada Announces Closing of $5 Million Financing

Ottawa, Canada March 20, 2018 – Orion Biotechnology Canada Ltd today announced it has completed a US$5 million private placement financing late last year. “We are delighted to have secured the financial resources during this period of rapid expansion,” said Mark Groper, President and Chief Executive Officer. “This financing allows Orion, as a private company, … Read moreOrion Biotechnology Canada Announces Closing of $5 Million Financing

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com